Pediatric Pathology : Emerging Entities, Current Trends, and Comprehensive Updates, “Histiocytosis” - 22/05/25
Abstract |
Histiocytic lesions, now classified as a myeloid-derived neoplasia, consist of mutated monocyte-derived dendritic and macrophage cells infiltrating tissues. They are primarily driven by kinase-activating alterations in mitogen-activated protein kinase (MAPK), Phosphatidylinositol 3-kinase (PI3K)/AKT, or other receptor tyrosine kinase (RTK) signalling pathways, leading to extracellular signal-regulated kinase (ERK) overexpression and growth survival. In children, these include Langerhans cell histiocytosis (LCH), juvenile xanthogranuloma (JXG), Rosai-Dorfman-Destombes disease (RDD), and ALK-positive histiocytosis. Additional diagnostic challenges are discussed including mixed histiocytosis and malignant histiocytic neoplasms (MHN), including Histiocytic Sarcoma and Langerhans cell sarcoma, described in terms of primary or secondary disease, if after a prior hematologic malignancy.
Le texte complet de cet article est disponible en PDF.Keywords : Langerhans cell histiocytosis (LCH), Juvenile xanthogranuloma (JXG), Rosai-Dorfman-Destombes disease (RDD), ALK-positive histiocytosis, Erdheim-Chester disease (ECD), Malignant histiocytic neoplasms (MHN), Macrophage, Dendritic cell
Plan
Vol 18 - N° 2
P. 341-358 - juin 2025 Retour au numéro
Article précédent
- Diagnostic Challenges and Updates in Peripheral Neuroblastic Tumors
- Jason Jarzembowski
- Cancer Predisposition Syndromes Associated with Most Common Pediatric Solid Tumors
- Jennifer C. Scull, Dolores Lopez-Terrada
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?